Airsculpt Technologies (AIRS) USD0.001

Sell:$5.20Buy:$5.59$0.66 (13.41%)

Prices delayed by at least 15 minutes
Sell:$5.20
Buy:$5.59
Change:$0.66 (13.41%)
Prices delayed by at least 15 minutes
Sell:$5.20
Buy:$5.59
Change:$0.66 (13.41%)
Prices delayed by at least 15 minutes

Company Information

About this company

AirSculpt Technologies, Inc., through its wholly owned subsidiaries, is a provider of practice management services to professional associations (PAs) located throughout the United States, Canada, and the United Kingdom. The Company owns and operates non-clinical assets and provides its management services to the PAs through management services agreements (MSAs). Its direct medical procedure services segment. The Company offers fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. Its AirSculpt + procedure permanently removes fat and tightens the skin with unparalleled precision and finesse.

Key people

Aaron Rollins
Executive Chairman of the Board
Todd Magazine
President
Yogesh Jashnani
Chief Executive Officer
Dennis Dean
Chief Financial Officer
Adam T. Feinstein
Lead Independent Director
Thomas J. Aaron
Independent Director
Caroline Chu
Independent Director
Kenneth Higgins
Independent Director
Daniel Sollof
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • ISIN
    US0094961002
  • Market cap
    $277.26m
  • Employees
    346
  • Shares in issue
    57.88m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.